1932

Abstract

Genetic analysis has allowed the dissection of the pathogenic pathway that leads to Alzheimer's disease. It has also been integral to the development of earlier and more accurate diagnostic practices. This analysis has identified many potential therapeutic targets, and clinical trials aimed at these targets are now under way. If these approaches are successful, it will be a spectacular validation of genetic-knowledge–based treatment strategies; if they are not, researchers will need to re-evaluate this approach toward understanding and developing strategies for treating complex diseases.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.55.091902.103607
2004-02-18
2024-04-24
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.55.091902.103607
Loading
/content/journals/10.1146/annurev.med.55.091902.103607
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error